163 related articles for article (PubMed ID: 18525017)
1. Central G-alpha subunit protein-mediated control of cardiovascular function, urine output, and vasopressin secretion in conscious Sprague-Dawley rats.
Wainford RD; Kurtz K; Kapusta DR
Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R535-42. PubMed ID: 18525017
[TBL] [Abstract][Full Text] [Related]
2. Chronic high-NaCl intake prolongs the cardiorenal responses to central N/OFQ and produces regional changes in the endogenous brain NOP receptor system.
Wainford RD; Kapusta DR
Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R280-8. PubMed ID: 18987291
[TBL] [Abstract][Full Text] [Related]
3. Centrally administered nociceptin/orphanin FQ (N/OFQ) evokes bradycardia, hypotension, and diuresis in mice via activation of central N/OFQ peptide receptors.
Burmeister MA; Kapusta DR
J Pharmacol Exp Ther; 2007 Jul; 322(1):324-31. PubMed ID: 17452419
[TBL] [Abstract][Full Text] [Related]
4. Nociceptin/orphanin FQ (N/OFQ)-evoked bradycardia, hypotension, and diuresis are absent in N/OFQ peptide (NOP) receptor knockout mice.
Burmeister MA; Ansonoff MA; Pintar JE; Kapusta DR
J Pharmacol Exp Ther; 2008 Sep; 326(3):897-904. PubMed ID: 18539652
[TBL] [Abstract][Full Text] [Related]
5. Functional selectivity of central Gα-subunit proteins in mediating the cardiovascular and renal excretory responses evoked by central α(2) -adrenoceptor activation in vivo.
Wainford RD; Kapusta DR
Br J Pharmacol; 2012 May; 166(1):210-20. PubMed ID: 21895632
[TBL] [Abstract][Full Text] [Related]
6. Functional selectivity of nociceptin/orphanin FQ peptide receptor partial agonists on cardiovascular and renal function.
Kapusta DR; Burmeister MA; Calo' G; Guerrini R; Gottlieb HB; Kenigs VA
J Pharmacol Exp Ther; 2005 Aug; 314(2):643-51. PubMed ID: 15855356
[TBL] [Abstract][Full Text] [Related]
7. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats.
Kapusta DR; Chang JK; Kenigs VA
J Pharmacol Exp Ther; 1999 Apr; 289(1):173-80. PubMed ID: 10087001
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular and renal responses produced by central orphanin FQ/nociceptin occur independent of renal nerves.
Kapusta DR; Kenigs VA
Am J Physiol; 1999 Oct; 277(4):R987-95. PubMed ID: 10516236
[TBL] [Abstract][Full Text] [Related]
9. Tonic nociceptinergic inputs to neurons in the hypothalamic paraventricular nucleus contribute to sympathetic vasomotor tone and water and electrolyte homeostasis in conscious rats.
Krowicki ZK; Kapusta DR
J Pharmacol Exp Ther; 2006 Apr; 317(1):446-53. PubMed ID: 16407463
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamic paraventricular nucleus G alpha q subunit protein pathways mediate vasopressin dysregulation and fluid retention in salt-sensitive rats.
Wainford RD; Kapusta DR
Endocrinology; 2010 Nov; 151(11):5403-14. PubMed ID: 20861238
[TBL] [Abstract][Full Text] [Related]
11. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
[TBL] [Abstract][Full Text] [Related]
12. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ).
Kapusta DR; Sezen SF; Chang JK; Lippton H; Kenigs VA
Life Sci; 1997; 60(1):PL15-21. PubMed ID: 8995537
[TBL] [Abstract][Full Text] [Related]
13. Nociceptin/orphanin FQ modulates the cardiovascular, but not renal, responses to stress in spontaneously hypertensive rats.
Kapusta DR; Dayan LA; Kenigs VA
Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):254-9. PubMed ID: 11906494
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and renal effects of nociceptin/orphanin FQ: a new mediator to target?
Doggrell SA
Curr Opin Investig Drugs; 2007 Sep; 8(9):742-9. PubMed ID: 17729186
[TBL] [Abstract][Full Text] [Related]
15. Role of endogenous nociceptin in the regulation of arginine vasopressin release in conscious rats.
Kakiya S; Murase T; Arima H; Yokoi H; Iwasaki Y; Miura Y; Oiso Y
Endocrinology; 2000 Dec; 141(12):4466-71. PubMed ID: 11108256
[TBL] [Abstract][Full Text] [Related]
16. Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol.
Bojnik E; Babos F; Fischetti C; Magyar A; Camarda V; Borsodi A; Bajusz S; Calo' G; Benyhe S
Brain Res Bull; 2010 Mar; 81(4-5):477-83. PubMed ID: 19800951
[TBL] [Abstract][Full Text] [Related]
17. Central nociceptin/orphanin FQ system elevates food consumption by both increasing energy intake and reducing aversive responsiveness.
Olszewski PK; Grace MK; Fard SS; Le Grevès M; Klockars A; Massi M; Schiöth HB; Levine AS
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R655-63. PubMed ID: 20427724
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures.
Bregola G; Zucchini S; Rodi D; Binaschi A; D'Addario C; Landuzzi D; Reinscheid R; Candeletti S; Romualdi P; Simonato M
J Neurosci; 2002 Nov; 22(22):10030-8. PubMed ID: 12427860
[TBL] [Abstract][Full Text] [Related]
19. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
[TBL] [Abstract][Full Text] [Related]
20. Distinct effect of intracerebroventricular and intrathecal injections of nociceptin/orphanin FQ in the rat formalin test.
Wang JL; Zhu CB; Cao XD; Wu GC
Regul Pept; 1999 Feb; 79(2-3):159-63. PubMed ID: 10100930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
